DAVIS STEPHEN

CIK 00011311467 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001131146

Recent Transactions

50 trades

Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-19$15.28/sh−31,747→ 186,555 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-16+44,782→ 218,302 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-08-16+17,333→ 173,520 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-02$16.94/sh−11,427→ 155,231 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-05-01−22,391→ 67,173 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-05-01+22,391→ 166,658 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-08$17.87/sh−8,858→ 161,983 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-08$17.87/sh−17,716→ 144,267 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-04-05−17,333→ 34,667 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-04-05−34,666→ 138,666 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-05+34,666→ 170,841 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-04-05+17,333→ 136,175 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-03-27$17.90/sh−17,714→ 118,842 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2024-03-25+286,451→ 286,451 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-03-25+34,666→ 136,556 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-02-26$24.67/sh−5,577→ 101,890 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-02-23−10,946→ 10,946 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-02-23+10,946→ 107,467 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-01-08$29.96/sh−3,732→ 96,521 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2024-01-06+9,528→ 100,253 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2024-01-06−9,528→ 0 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-10-06−103,999→ 173,332 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-10-06$21.96/sh−51,563→ 89,131 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-10-05+103,999→ 140,694 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Stock Option (Right to Buy)
2023-07-14−100,000→ 220,000 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-07-14$20.77/sh+100,000→ 136,695 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-07-14$30.04/sh−100,000→ 36,695 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-07-12$25.05/sh−55,104→ 36,695 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-07-11$25.00/sh−16,498→ 91,799 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-05-01+89,564→ 89,564 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-05-01$21.18/sh−7,806→ 108,297 total
Award
ACADIA PHARMACEUTICALS INC$ACAD
Stock Options (Right to Buy)
2023-05-01+295,503→ 295,503 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-04-29+15,625→ 116,103 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-04-29−15,625→ 0 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-04-06$18.16/sh−8,582→ 100,478 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-04-05−17,333→ 52,000 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-04-05+17,333→ 109,060 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-02-24$18.78/sh−3,851→ 91,727 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-02-23−10,945→ 21,892 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-02-23+10,945→ 95,578 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-01-09$17.13/sh−3,904→ 84,633 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2023-01-06−9,528→ 9,528 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2023-01-06+9,528→ 88,537 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2023-01-03+74,739→ 136,854 total
Award
HERON THERAPEUTICS, INC. /DE/$HRTX
Stock Option (Right to Buy)
2022-12-16+77,160→ 77,160 total
Award
HERON THERAPEUTICS, INC. /DE/$HRTX
Common Stock
2022-12-16+38,580→ 52,032 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2022-10-15+5,938→ 81,813 total
Sale
ACADIA PHARMACEUTICALS INC$ACAD
Common Stock
2022-10-15$15.81/sh−2,804→ 79,009 total
Exercise/Conversion
ACADIA PHARMACEUTICALS INC$ACAD
Restricted Stock Units
2022-10-15−5,938→ 0 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2022-09-01+43,400→ 62,115 total

Companies

Recent Filings

Address

TRIMERIS, INC 2530 MERIDIAN PKWY, 2ND FLOOR

DURHAM, NC, 27713

View on SEC.gov